Diken M - Search Results

1

Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation.

Diken M, Kreiter S, Selmi A, Britten CM, Huber C, Türeci Ö, Sahin U. Diken M, et al. Gene Ther. 2011 Jul;18(7):702-8. doi: 10.1038/gt.2011.17. Epub 2011 Mar 3. Gene Ther. 2011. PMID: 21368901

2

Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals.

Kreiter S, Selmi A, Diken M, Sebastian M, Osterloh P, Schild H, Huber C, Türeci O, Sahin U. Kreiter S, et al. Among authors: diken m. J Immunol. 2008 Jan 1;180(1):309-18. doi: 10.4049/jimmunol.180.1.309. J Immunol. 2008. PMID: 18097032

3

CIMT 2009: report on the seventh annual meeting of the association for immunotherapy of cancer. June 3-5, Mainz, Germany.

Diken M, Widenmeyer M, Gouttefangeas C, Welters MJ, Britten CM. Diken M, et al. Cancer Immunol Immunother. 2010 Sep;59(9):1417-23. doi: 10.1007/s00262-009-0770-z. Epub 2009 Sep 22. Cancer Immunol Immunother. 2010. PMID: 19771427 Free PMC article. No abstract available.

4

Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo.

Kuhn AN, Diken M, Kreiter S, Selmi A, Kowalska J, Jemielity J, Darzynkiewicz E, Huber C, Türeci O, Sahin U. Kuhn AN, et al. Among authors: diken m. Gene Ther. 2010 Aug;17(8):961-71. doi: 10.1038/gt.2010.52. Epub 2010 Apr 22. Gene Ther. 2010. PMID: 20410931

5

Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity.

Kreiter S, Selmi A, Diken M, Koslowski M, Britten CM, Huber C, Türeci O, Sahin U. Kreiter S, et al. Among authors: diken m. Cancer Res. 2010 Nov 15;70(22):9031-40. doi: 10.1158/0008-5472.CAN-10-0699. Epub 2010 Nov 2. Cancer Res. 2010. PMID: 21045153

6

Determinants of intracellular RNA pharmacokinetics: Implications for RNA-based immunotherapeutics.

Kuhn AN, Diken M, Kreiter S, Vallazza B, Türeci Ö, Sahin U. Kuhn AN, et al. Among authors: diken m. RNA Biol. 2011 Jan-Feb;8(1):35-43. doi: 10.4161/rna.8.1.13767. Epub 2011 Jan 1. RNA Biol. 2011. PMID: 21289486 Free article.

7

Tumor vaccination using messenger RNA: prospects of a future therapy.

Kreiter S, Diken M, Selmi A, Türeci Ö, Sahin U. Kreiter S, et al. Among authors: diken m. Curr Opin Immunol. 2011 Jun;23(3):399-406. doi: 10.1016/j.coi.2011.03.007. Epub 2011 Apr 13. Curr Opin Immunol. 2011. PMID: 21497074 Review.

8

FLT3 ligand enhances the cancer therapeutic potency of naked RNA vaccines.

Kreiter S, Diken M, Selmi A, Diekmann J, Attig S, Hüsemann Y, Koslowski M, Huber C, Türeci Ö, Sahin U. Kreiter S, et al. Among authors: diken m. Cancer Res. 2011 Oct 1;71(19):6132-42. doi: 10.1158/0008-5472.CAN-11-0291. Epub 2011 Aug 4. Cancer Res. 2011. PMID: 21816907

9

Exploiting the mutanome for tumor vaccination.

Castle JC, Kreiter S, Diekmann J, Löwer M, van de Roemer N, de Graaf J, Selmi A, Diken M, Boegel S, Paret C, Koslowski M, Kuhn AN, Britten CM, Huber C, Türeci O, Sahin U. Castle JC, et al. Among authors: diken m. Cancer Res. 2012 Mar 1;72(5):1081-91. doi: 10.1158/0008-5472.CAN-11-3722. Epub 2012 Jan 11. Cancer Res. 2012. PMID: 22237626 Free article.

10

Confidence-based somatic mutation evaluation and prioritization.

Löwer M, Renard BY, de Graaf J, Wagner M, Paret C, Kneip C, Türeci O, Diken M, Britten C, Kreiter S, Koslowski M, Castle JC, Sahin U. Löwer M, et al. Among authors: diken m. PLoS Comput Biol. 2012;8(9):e1002714. doi: 10.1371/journal.pcbi.1002714. Epub 2012 Sep 27. PLoS Comput Biol. 2012. PMID: 23028300 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters